Zithromax, Zmax (azithromycin): FDA Warning – Increased Risk of Cancer Relapse With Long-Term Use After Donor Stem Cell Transplant
Murilo Freitas - 14:00, 2 de agosto de 2018634
0
The antibiotic Zithromax, Zmax (azithromycin) should not be given long-term to prevent a certain inflammatory lung condition in patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant. Results of a clinical trial found an increased rate of relapse in cancers affecting the blood and lymph nodes, including death, in these patients.